Sep 26 2025 This Week in Cardiology

A bold trial in valvular heart disease, a CV prevention trial whose message is humility, VTE dogma challenged, more news on oral GLP-1 agonists, and a few public service announcements are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I DOUBLE-CHOICE: Minimalist Approach to TAVI May Be as Good as Standard of Care https://www.medscape.com/viewarticle/... • Patient & Physician Perspectives on CV Risk https://www.ahajournals.org/doi/10.11... II KP Vaccinate Trial • KP Vaccinate Trial https://evidence.nejm.org/doi/full/10... • IAMI trial https://www.ahajournals.org/doi/10.11... • Increasing Flu Vaccinations in Patients With Chronic Disease https://jamanetwork.com/journals/jama... • MI FREEE Trial https://www.nejm.org/doi/full/10.1056... III Hi PRO Trial • Apixaban for Extended Treatment of VTE https://www.nejm.org/doi/full/10.1056... • Recurrent VTE in Patients with Provoked VTE https://jamanetwork.com/journals/jama... IV Oral GLP-1 Agonists • ATTAIN 1 Trial https://www.nejm.org/doi/full/10.1056... You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-h... Questions or feedback, please contact [email protected]